A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin

Trial Profile

A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Paracetamol (Primary)
  • Indications Fever
  • Focus Therapeutic Use
  • Sponsors Unipharma
  • Most Recent Events

    • 21 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 07 Dec 2015 Planned End Date changed from 1 Jul 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov
    • 07 Dec 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top